aposcience.at valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Aposcience AG: the secretome |
| Description | Aposcience AG – the secretome Home Contact Company Mission Statement Management Partners Technology Overview Pre-Clinical GMP Manufacturing Clinical Klinische Studie Clinical Trial New |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 81.19.145.154 |
| Location | Austria |
Related Websites
| Site | Rank |
More to Explore
aposcience.at Valuation
|
US$395,076
Last updated: 2022-10-20 12:35:40
aposcience.at has Semrush global rank of 26,790,587. aposcience.at has an estimated worth of US$ 395,076, based on its estimated Ads revenue. aposcience.at receives approximately 45,586 unique visitors each day. Its web server is located in Austria, with IP address 81.19.145.154. According to SiteAdvisor, aposcience.at is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$395,076 |
| Daily Ads Revenue | US$365 |
| Monthly Ads Revenue | US$10,941 |
| Yearly Ads Revenue | US$131,287 |
| Daily Unique Visitors | 3,040 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| aposcience.at. | A | 3600 | IP: 81.19.145.154 |
| aposcience.at. | NS | 21600 | NS Record: ns1.world4you.at. |
| aposcience.at. | NS | 21600 | NS Record: ns2.world4you.at. |
| aposcience.at. | MX | 3600 | MX Record: 10 mail.aposcience.at. |
HtmlToTextCheckTime:2022-10-20 12:35:40
| Home Contact Company Mission Statement Management Partners Technology Overview Pre-Clinical GMP Manufacturing Clinical Klinische Studie Clinical Trial News News Archive Key Publications Events Focus Wound Healing Focus Myocardial Infarction The APOSEC Story Aposcience AG – the secretome company Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be functionally restored, rather than just repaired. The company’s proprietary technology is based on secretomes of white blood cells (peripheral blood mononuclear cells [PBMCs]). Aposcience develops its products for the treatment of impaired wound healing (e.g., diabetic ulcers and deep skin burn injury) and internal diseases that are related to ischemia induced inflammation (acute and chronic myocardial infarction, stroke, spinal cord injury). Latest News |
HTTP Headers
HTTP/1.1 302 Found Date: Thu, 24 Feb 2022 09:28:27 GMT Server: Apache Location: http://www.aposcience.at/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 24 Feb 2022 09:28:27 GMT Server: Apache Set-Cookie: fe_typo_user=c2d4bb0ccdc55c3caa3ce6ab744d0cc3; path=/ Content-Type: text/html; charset=utf-8 |